Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-03-12

Clinical Trial Update: Study Evaluating Patients With Cystinuria [Phase 2, Phase 3]

View source ↗

Summary

A cystinuria clinical trial (Phase 2/3) sponsored by Advicenne Pharma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Advicenne Pharma | Conditions: Cystinuria | Phase 2, Phase 3 | Status: WITHDRAWN